X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62) 62
humans (59) 59
male (44) 44
oncology (39) 39
child (38) 38
female (36) 36
cancer (29) 29
abstracts (28) 28
child, preschool (28) 28
infant (25) 25
life sciences (23) 23
children (22) 22
adolescent (21) 21
pediatrics (20) 20
clinical neurology (19) 19
chemotherapy (18) 18
radiotherapy (16) 16
tumors (16) 16
prognosis (15) 15
adult (13) 13
health aspects (13) 13
retrospective studies (13) 13
surgery (13) 13
central-nervous-system (12) 12
hematology (12) 12
medulloblastoma (12) 12
research (12) 12
risk factors (12) 12
brain tumors (11) 11
medicine & public health (11) 11
animals (10) 10
care and treatment (10) 10
neurosciences (10) 10
treatment outcome (10) 10
young adult (9) 9
analysis (8) 8
antineoplastic agents - therapeutic use (8) 8
brain (8) 8
brain neoplasms - therapy (8) 8
combined modality therapy (8) 8
diagnosis (8) 8
high-dose chemotherapy (8) 8
infant, newborn (8) 8
magnetic resonance imaging (8) 8
mutations (8) 8
radiation (8) 8
therapy (8) 8
[ sdv.can ] life sciences [q-bio]/cancer (7) 7
brain neoplasms - pathology (7) 7
follow-up studies (7) 7
gliomas (7) 7
management (7) 7
medulloblastoma - genetics (7) 7
pathology (7) 7
age (6) 6
brain-tumors (6) 6
cerebellar neoplasms - genetics (6) 6
france (6) 6
gene expression profiling (6) 6
immunohistochemistry (6) 6
metastases (6) 6
mice (6) 6
middle aged (6) 6
biochemistry & molecular biology (5) 5
cell biology (5) 5
cellular biology (5) 5
cerebellar neoplasms - pathology (5) 5
childhood (5) 5
childhood medulloblastoma (5) 5
disease-free survival (5) 5
human health and pathology (5) 5
kaplan-meier estimate (5) 5
medulloblastoma - therapy (5) 5
metastasis (5) 5
neurotensin (5) 5
radiation therapy (5) 5
signal transduction (5) 5
activation (4) 4
article (4) 4
brain cancer (4) 4
cells, cultured (4) 4
central nervous system neoplasms - pathology (4) 4
cerebellar neoplasms - mortality (4) 4
cerebellar neoplasms - therapy (4) 4
clinical investigations (4) 4
complications and side effects (4) 4
dose-response relationship, drug (4) 4
endocrinology & metabolism (4) 4
expression (4) 4
gene expression regulation, neoplastic (4) 4
genetic aspects (4) 4
genetic predisposition to disease (4) 4
hematology, oncology and palliative medicine (4) 4
irradiation (4) 4
medulloblastoma - mortality (4) 4
medulloblastoma - pathology (4) 4
metabolism (4) 4
multidisciplinary sciences (4) 4
mutation (4) 4
neoplasms (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatric Blood & Cancer, ISSN 1545-5009, 06/2014, Volume 61, Issue 6, pp. 1101 - 1103
We present three pediatric patients with BRAFV600E mutant high-grade gliomas treated by vemurafenib on a nominative authorization level at our institution. One... 
pharmacokinetics | vemurafenib | BRAF | anaplastic ganglioglioma | mutations | pediatric brain tumors | Vemurafenib | Pharmacokinetics | Anaplastic ganglioglioma | Pediatric brain tumors | BRAF mutations | MELANOMA | ONCOLOGY | METASTASES | PEDIATRICS | HEMATOLOGY | Proto-Oncogene Proteins B-raf - physiology | Humans | Male | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Mutation, Missense | Protein Kinase Inhibitors - adverse effects | Bevacizumab | Cancer Vaccines - therapeutic use | Immunotherapy | Fatal Outcome | Camptothecin - administration & dosage | Thalamus | Antineoplastic Agents - pharmacokinetics | Ganglioglioma - surgery | Neoplasm Proteins - genetics | Child | Camptothecin - analogs & derivatives | Protein Kinase Inhibitors - pharmacokinetics | Ganglioglioma - drug therapy | Dacarbazine - administration & dosage | Ganglioglioma - radiotherapy | Combined Modality Therapy | Brain Neoplasms - drug therapy | Sulfonamides - pharmacokinetics | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Indoles - adverse effects | Indoles - therapeutic use | Neoplasm Proteins - physiology | Drug Evaluation | Salvage Therapy | Infant | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Doxorubicin - analogs & derivatives | Ganglioglioma - enzymology | Astrocytoma - enzymology | Doxorubicin - administration & dosage | Brain Neoplasms - enzymology | Treatment Outcome | Cranial Irradiation | Polyethylene Glycols - administration & dosage | Point Mutation | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Sulfonamides - adverse effects | Indoles - pharmacokinetics | Pediatrics | Children | Gliomas | Health aspects
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2016, Volume 11, Issue 6, p. e0157139
Journal Article
European heart journal, ISSN 0195-668X, 2015, Volume 36, Issue 43, pp. 2996 - 3003
Journal Article
BMC Cancer, ISSN 1471-2407, 02/2018, Volume 18, Issue 1, pp. 177 - 177
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 11/2016, Volume 17, Issue 11, pp. 1860 - 1860
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 20, pp. 6101 - 6112
Journal Article
Journal Article
Journal Article
Journal Article